BLOG

With a $17 million grant, UCSF Benioff Children’s Hospital in

The FDA has granted accelerated designation to PRGN-3006 for the

Mucopolysaccharidosis I is caused by mutations in the gene for

In the process of engineering CAR T cells, if the

Many people are excluded from CAR T cell-based treatments because

CAR T-cell therapy and antibody treatments are two types of

CARCIK-CD19, an investigational therapy developed by scientists in Italy, involves

The mammalian brain contains many specialized cells that develop from

CRISPR genome editing has served as a powerful tool to